Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Prostate cancer screening].

Arnauld Villers, Xavier Rébillard, Michel Soulié

    Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
    |May 27, 2003
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    ISUP 2 prostate cancer with suspicion of extraprostatic extension on MRI: Prostatectomy results and oncologic outcomes.

    Urologic oncology·2026
    Same author

    PI-RADS v2 and Adverse Prostate Cancer Outcomes: A Cross-cohort Replication Study Across Three Centers.

    European urology oncology·2026
    Same author

    Salvage High-intensity Focused Ultrasound for Prostate Cancer Recurrence after Radiotherapy (HIFI-2 Study).

    European urology oncology·2026
    Same author

    Unveiling the Clinical Potential of Prostate Cancer Three-dimensional Models: A Systematic Review.

    European urology oncology·2026
    Same author

    Robot-assisted versus open surgery for multiple ipsilateral renal tumors: a multicenter matched cohort study (UroCCR-60).

    Journal of robotic surgery·2026
    Same author

    ARCHES 5-year Survival with Enzalutamide Plus Androgen-deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients.

    European urology·2026
    Same journal

    ["Connected device for monitoring patients treated by prostatectomy: Implementation and qualitative assessment"].

    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2024
    Same journal

    [Role of nurses specializing in oncology to support the care journey for patients with penile cancer].

    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2024
    Same journal

    [Pre- and post-prostatectomy rehabilitation by the certified nurse-urologist pair (REHAB): Feasibility study].

    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2024
    Same journal

    [Genitourinary complications after pelvic radiotherapy: Diagnosis and management].

    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2024
    Same journal

    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
    Same journal

    [Male contraception].

    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
    See all related articles

    Prostate cancer screening using prostate specific antigen (PSA) testing and digital rectal exams is recommended annually for men aged 50-75. Early detection improves cure rates for this common male cancer.

    Area of Science:

    • Oncology
    • Public Health
    • Urology

    Context:

    • Prostate cancer is the most frequent cancer and second leading cause of cancer mortality in men.
    • Increasing life expectancy contributes to the growing public health importance of prostate cancer.
    • Current lifetime diagnosis rate is 1 in 8 men, representing 25% of all new male cancer cases.

    Purpose:

    • To provide recommendations for the optimal use of prostate cancer screening tests.
    • To inform general practitioners and specialists about screening modalities.
    • To define target populations, screening tests, and pre-screening information.

    Summary:

    • The French Urology Association recommends annual prostate cancer screening via prostate specific antigen (PSA) assay and digital rectal examination for men aged 50-75.

    Related Experiment Videos

  • Screening should commence at age 45 for men with family or ethnic risk factors.
  • Referral to a urologist is advised for abnormal PSA levels or digital rectal examination findings.

    • Impact:

    • Aims to improve early-stage detection of prostate cancer, thereby increasing chances of cure.
    • Provides guidance for healthcare professionals on informed decision-making regarding screening.
    • Emphasizes the importance of comprehensive patient information on screening benefits, risks, and treatment options.